Clover Co. Limited (ASX:CLV)’s stock price traded up 4.1% on Monday . The company traded as high as A$2.82 ($2.00) and last traded at A$2.81 ($1.99), 120,211 shares changed hands during trading. A decline of 6% from the average session volume of 127,440 shares. The stock had previously closed at A$2.70 ($1.91).
The stock has a market cap of $454.03 million and a price-to-earnings ratio of 44.75. The company has a current ratio of 3.15, a quick ratio of 1.52 and a debt-to-equity ratio of 29.82. The company’s fifty day moving average is A$2.69 and its two-hundred day moving average is A$2.53.
In other Clover news, insider Peter Davey sold 155,600 shares of the company’s stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of A$2.52 ($1.79), for a total transaction of A$391,645.20 ($277,762.55).
Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. The company is also involved in the production of encapsulated powders; and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milk products, and food applications; and Nu-Mega Driphorm HA for non-dairy applications.
Further Reading: Municipal Bonds
Receive News & Ratings for Clover Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover and related companies with MarketBeat.com's FREE daily email newsletter.